Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells

Leukemia

Volumn 13, Issue 5, 1999, Pages 719-728

  Fadeel, B ^a,b   Hassan, Z ^a,b   Hellstrom Lindberg E ^a,b   Henter, J I ^b   Orrenius, S ^a   Zhivotovsky, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Bcl 2; Caspases; Chemotherapy; Cleavage

Indexed keywords

CASPASE; CASPASE 3; CASPASE INHIBITOR; ETOPOSIDE; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; EPITOPE MAPPING; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRION; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTO ONCOGENE;

EID: 0033049597     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401411     Document Type: Article

References (43)

1. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997; 88: 347-354.
2. Zhivotovsky B, Burgess DH, Vanags DM, Orrenius S. Involvement of cellular proteolytic machinery in apoptosis. Biochem Biophys Res Comm 1997; 230: 481-488.
3. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biol Sci 1997; 22: 299-306.
4. Cardone M, Salvesen GS, Widmann C, Johnson GL, Frisch SM. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 1997; 90: 315-323.
5. Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997; 276: 1571-1574.
6. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT. Caspase-3-generated fragment of gelsolin: effector of morphological changes in apoptosis. Science 1997; 278: 294-298.
7. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996; 88: 386-410.
8. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993; 53: 4701-4714.
9. Yang J, Xuesong L, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome-c from mitochondria blocked. Science 1997; 275: 1129-1132.
10. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome-c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-1136.
11. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 1997; 3: 614-620.
12. Zhivotovsky B, Orrenius S, Brustugun OT, Døskeland SO. Injected cytochrome-c induces apoptosis. Nature 1998; 391: 449-450.
13. L inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 1998; 95: 4386-4391.
14. L, and Apaf-1 form a ternary complex. J Biol Chem 1998; 273: 5841-5845.
15. Cheng EH-Y, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM. Conversion of bcl-2 to a bax-like death effector by caspases. Science 1997; 278: 1966-1968.
16. L through caspase interaction. Proc Natl Acad Sci USA 1998; 95: 554-559.
17. Greenberg PL. The myelodysplastic syndromes. In: Hoffman R, Benz E, Shattil S, Furie B, Cohen H (eds). Hematology: Basic Principles and Practice. Churchill Livingstone: New York, 1994, pp 1098-1121.
18. Yoshida Y, Anzai N, Kawabata H. Apoptosis in myelodysplasia: a paradox or paradigm. Leukemia Res 1995; 19: 887-891.
19. Nagai M, Seki S, Kitahara T, Abe T, Minato K, Watanabe S, Shimoyama M. A novel human myelomonocytoid cell line, P39/Tsugane, derived from overt leukemia following myelodysplastic syndrome. Gann 1984; 75: 1100-1107.
20. Anzai N, Kawabata H, Hirama T, Masutani H, Ohmori M, Yoshida Y, Okuma M. Marked apoptosis of human myelomonocytic leukemia cell line P39: significance of cellular differentiation. Leukemia 1994; 8: 446-453.
21. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti MA, Della Porta G. Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992; 79: 1291-1298.
22. Benito A, Grillot D, Nunez C, Fernández-Luna JL. Regulation and function of bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am J Pathol 1995; 146: 481-490.
23. Fadeel B, Åhlin A, Henter J-I, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 1998; 92: 4808-4818.
24. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
25. Samali A, Zhivotovsky B, Jones DP, Orrenius S. Detection of procaspase-3 in cytosol and mitochondria of various tissues. FEBS Lett 1998; 431: 167-169.
26. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other anticancer drugs: a cautionary note. Cancer Res 1989; 49: 5870-5878.
27. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990; 40: 2353-2362.
28. Bertrand R, Sarang M, Jenkin J, Kerrigan D, Pommier Y. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res 1991; 51: 6280-6285.
29. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997; 272: 17907-17911.
30. Martins LM, Kottke T, Mesner PW, Basi GS, Sinha S, Frigon N Jr, Tatar E, Tung JS, Bryant K, Takahashi A, Svingen PA, Madden BJ, McCormick DJ, Earnshaw WC, Kaufmann SH. Activation of multiple interleukin-1β converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J Biol Chem 1997; 272: 7421-7430.
31. Faleiro L, Kobayasi R, Fearnhead H, Lazebnik Y. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J 1997; 16: 2271-2281.
32. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-3985.
33. Grandgirard D, Studer E, Monney L, Belser T, Fellay I, Borner C, Michel MR. Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J 1998; 17: 1268-1278.
34. L protein by caspase-3-like proteases. Oncogene 1998; 17: 1295-1304.
35. Yamamoto AM, Eloy L, Bach J-F, Garchon H-J. N-terminus cleavage of bcl-2 by a novel cellular non-ICE cysteine proteinase. Leukemia 1998; 12: 1467-1472.
36. Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson EP, Casciola-Rosen LA, Rosen A. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol 1998; 140: 1485-1495.
37. Otter I, Conus S, Ravn U, Rager M, Olivier R, Monney L, Fabbro D, Borner C. The binding properties and biological activities of bcl-2 and bax in cells exposed to apoptotic stimuli. J Biol Chem 1998; 273: 6110-6120.
38. Xue D, Horvitz HR. Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor. Nature 1997; 390: 305-308.
39. Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997; 89: 1845-1853.
40. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539-542.
41. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799-1805.
42. Haldar S, Jena N, Croce CM. Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 1995; 92: 4507-4511.
43. Gajewski TF, Thompson CB. Apoptosis meets signal transduction: elimination of a BAD influence. Cell 1996; 87: 589-592.